PRDM2 antibody
Principal name
PRDM2 antibody
Alternative names for PRDM2 antibody
PR domain zinc finger protein 2, KMT8, RIZ1, RIZ2, MTB-ZF, HUMHOXY1, Retinoblastoma protein-interacting zinc finger protein, MTE-binding protein, GATA-3-binding protein G3B, Lysine N-methyltransferase 8
Ncbi ID
9606, 10116, 5874, NM_001135610, NP_001129082, NP_001007258.1, NM_001007257
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF), Immunoprecipitation (IP), ChIP assay (ChIP), Paraffin Sections (P)
Background of PRDM2 antibody
Similar to acetylation and phosphorylation, histone methylation at the N-terminal tail has emerged as an important role in regulating chromatin dynamics and gene activity. Histone methylation occurs on arginine and lysine residues and is catalyzed by two families of proteins, the protein arginine methyltransferase family and the SET-domain-containing methyltransferase family. Five members have been identified in the arginine methyltransferase family. About 27 are grouped into the SET-domain family, and another 17 make up the PR domain family that is related to the SET domain family. The retinoblastoma protein-interacting zinc finger geneRIZ1 is a tumor suppressor gene and a FOUNDING member of the PR domain family. RIZ1 inactivation is commonly found in many types of human cancers and occurs through loss of mRNA expression, frame shift mutation, chromosomal deletion, and missense mutation. RIZ1 is also a tumor susceptibility gene in mice. The loss of RIZ1 mRNA in human cancers was shown to associate with DNA methylation of its promoter CpG island. Methylation of the RIZ1 promoter strongly correlated with lost or decreased RIZ1 mRNA expression in breast, liver, colon, and lung cancer cell lines as well as in liver cancer tissues.





Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA351337 | PRDM2 antibody |
||||||
| Rabbit Polyclonal Anti-PRDM2 Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AM11041PU-N | PRDM2 (1-347) antibody |
||||||
![]() |
Mouse | IgG1 | 33AT1045 | Purified | Hu, Ms | WB |
0.4 ml /
€415.00
|
| OriGene Technologies GmbH | |||||||
| AP11193PU-N | PRDM2 antibody |
||||||
![]() |
Rabbit | Ig | Purified | Hu, Ms, Rt | IP, P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN214550 | PRDM2 - human gene knockout kit via CRISPR |
||
![]() |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN214550BN | PRDM2 - human gene knockout kit via CRISPR |
||
![]() |
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN214550LP | PRDM2 - human gene knockout kit via CRISPR |
||
![]() |
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN214550RB | PRDM2 - human gene knockout kit via CRISPR |
||
![]() |
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP327715 | PRDM2 (transcript variant 4) |
||||
| Recombinant protein of human PR domain containing 2, with ZNF domain (PRDM2), transcript variant 4 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY427635 | PRDM2 overexpression lysate |
|
![]() |
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC214926L2V | Lenti ORF particles, PRDM2 (mGFP-tagged)-Human PR domain containing 2, with ZNF domain (PRDM2), transcript variant 3, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€2,680.00
|
|
| OriGene Technologies, Inc. | ||
| RC214926L1V | Lenti ORF particles, PRDM2 (Myc-DDK-tagged)-Human PR domain containing 2, with ZNF domain (PRDM2), transcript variant 3, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€2,420.00
|
|
| OriGene Technologies, Inc. | ||



![Figure 1. Western blot analysis of anti-PRDM2 Mab (Cat. #AM11041P) in lysate from transformed cells. Lane A: mock plasmid, Lane B: PRDM2[1-347]-encoding plasmid. PRDM2[1-347] (arrow) was detected using purified Mab. Secondary HRP-anti-mouse was used for signal visualization with chemiluminescence.](https://m1.acris-antibodies.com/catalog/product/cache/1/small_image/50x50/9df78eab33525d08d6e5fb8d27136e95/0102778.jpeg)

+1 additional image